Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Rockwell Medical (RMTI) FCF Margin (2016 - 2025)

Historic FCF Margin for Rockwell Medical (RMTI) over the last 17 years, with Q3 2025 value amounting to 9.96%.

  • Rockwell Medical's FCF Margin fell 243800.0% to 9.96% in Q3 2025 from the same period last year, while for Sep 2025 it was 3.95%, marking a year-over-year decrease of 66100.0%. This contributed to the annual value of 3.14% for FY2024, which is 147400.0% up from last year.
  • Per Rockwell Medical's latest filing, its FCF Margin stood at 9.96% for Q3 2025, which was down 243800.0% from 10.53% recorded in Q2 2025.
  • Over the past 5 years, Rockwell Medical's FCF Margin peaked at 14.42% during Q3 2024, and registered a low of 81.0% during Q1 2021.
  • Moreover, its 5-year median value for FCF Margin was 11.11% (2024), whereas its average is 19.77%.
  • As far as peak fluctuations go, Rockwell Medical's FCF Margin tumbled by -384900bps in 2021, and later skyrocketed by 575800bps in 2022.
  • Quarter analysis of 5 years shows Rockwell Medical's FCF Margin stood at 59.61% in 2021, then skyrocketed by 97bps to 2.03% in 2022, then skyrocketed by 81bps to 0.39% in 2023, then soared by 590bps to 1.91% in 2024, then plummeted by -623bps to 9.96% in 2025.
  • Its last three reported values are 9.96% in Q3 2025, 10.53% for Q2 2025, and 18.84% during Q1 2025.